Adagio Therapeutics (ADGI) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Adagio Therapeutics (ADGI) Stock Forecast for 2024–2028. Sell or Buy?

Updated: July 15, 2024 (07:12)

Sector: Healthcare

The share price of Adagio Therapeutics, Inc. (ADGI) now

This company is DELISTED
Latest session on the 15th of July for
Adagio Therapeutics, Inc. is negative
Trading Volume:
Open: 0 /  High: 0 /  Low: 0
What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Adagio Therapeutics stocks, the 50-day moving average is the support level today.

For Adagio Therapeutics stocks, the 200-day moving average is the support level today.

Are you interested in Adagio Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Adagio Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one Adagio Therapeutics share be worth in 2024 - 2028?

When should I take profit in Adagio Therapeutics stock? When should I record a loss on Adagio Therapeutics stock? What are analysts' forecasts for Adagio Therapeutics stock? What is the future of Adagio Therapeutics stock? We forecast Adagio Therapeutics stock performance using neural networks based on historical data on Adagio Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Adagio Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Adagio Therapeutics shares. This happens once a day.


Historical and forecast chart of Adagio Therapeutics stock

The chart below shows the historical price of Adagio Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Adagio Therapeutics stock price can be found in the table below.

No data

Long-term forecasts by years.

Adagio Therapeutics, Inc., a clinical biopharmaceutical company, is engaged in the discovery, development and commercialization of antibody-based solutions for the treatment of infectious diseases in the United States. Its main product candidate is ADG20, a neutralizing antibody undergoing phase II / III clinical trials for the treatment and prevention of coronavirus disease. The company has entered into a collaboration agreement with Adimab, LLC in the area of proprietary antibody detection and optimization. Adagio Therapeutics, Inc.

Adagio Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 17 5.01 4.96 5.08 2.43
Jul 18 5.10 4.92 5.21 5.91
Jul 19 5.13 5.06 5.29 4.61
Jul 20 5.02 4.94 5.17 4.63
Jul 21 5.01 4.85 5.17 6.72
Jul 22 5.24 5.12 5.37 4.81
Jul 23 5.11 5.03 5.30 5.23
Jul 24 5.03 4.88 5.15 5.46
Jul 25 5.21 5.06 5.28 4.37
Jul 26 5.27 5.07 5.47 7.85
Jul 27 5.26 5.17 5.33 3.00
Jul 28 5.28 5.08 5.36 5.52
Jul 29 5.44 5.34 5.52 3.26
Jul 30 5.57 5.39 5.63 4.39
Jul 31 5.55 5.48 5.77 5.27
Aug 01 5.62 5.54 5.78 4.31
Aug 02 5.78 5.66 5.99 5.98
Aug 03 5.85 5.77 6.00 4.00
Aug 04 5.70 5.54 5.81 4.89
Aug 05 5.60 5.51 5.75 4.32
Aug 06 5.60 5.46 5.66 3.69
Aug 07 5.71 5.49 5.79 5.52
Aug 08 5.85 5.72 5.94 3.84
Aug 09 5.80 5.62 5.94 5.78
Aug 10 5.67 5.59 5.87 5.02
Aug 11 5.93 5.77 6.13 6.27
Aug 12 5.79 5.74 5.86 2.12
Aug 13 5.90 5.74 5.99 4.47
Aug 14 5.82 5.59 6.03 7.91
Aug 15 5.71 5.54 5.91 6.54

Adagio Therapeutics Daily Price Targets


Adagio Therapeutics Stock Forecast 07-17-2024.

Forecast target price for 07-17-2024: $5.01.
Positive dynamics for Adagio Therapeutics shares will prevail with possible volatility of 2.368%.
Pessimistic target level: 4.96
Optimistic target level: 5.08

Adagio Therapeutics Stock Forecast 07-18-2024.

Forecast target price for 07-18-2024: $5.10.
Positive dynamics for Adagio Therapeutics shares will prevail with possible volatility of 5.577%.
Pessimistic target level: 4.92
Optimistic target level: 5.21

Adagio Therapeutics Stock Forecast 07-19-2024.

Forecast target price for 07-19-2024: $5.13.
Positive dynamics for Adagio Therapeutics shares will prevail with possible volatility of 4.411%.
Pessimistic target level: 5.06
Optimistic target level: 5.29

Adagio Therapeutics Stock Forecast 07-20-2024.

Forecast target price for 07-20-2024: $5.02.
Negative dynamics for Adagio Therapeutics shares will prevail with possible volatility of 4.422%.
Pessimistic target level: 4.94
Optimistic target level: 5.17

Adagio Therapeutics Stock Forecast 07-21-2024.

Forecast target price for 07-21-2024: $5.01.
Negative dynamics for Adagio Therapeutics shares will prevail with possible volatility of 6.298%.
Pessimistic target level: 4.85
Optimistic target level: 5.17

Adagio Therapeutics Stock Forecast 07-22-2024.

Forecast target price for 07-22-2024: $5.24.
Positive dynamics for Adagio Therapeutics shares will prevail with possible volatility of 4.588%.
Pessimistic target level: 5.12
Optimistic target level: 5.37

ADGI (ADGI) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Aug. 5.15 4.52 5.70 20.61
Sep. 5.42 4.96 5.71 13.09
Oct. 5.65 5.30 5.96 11.17
Nov. 5.77 5.24 6.67 21.45
Dec. 5.33 4.55 6.17 26.12

Adagio Therapeutics forecast for this year


Adagio Therapeutics Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $5.152. Pessimistic: $4.52. Optimistic: $5.70


Adagio Therapeutics Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $5.4199. Pessimistic: $4.96. Optimistic: $5.71


Adagio Therapeutics Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $5.64754. Pessimistic: $5.30. Optimistic: $5.96


Adagio Therapeutics Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $5.77179. Pessimistic: $5.24. Optimistic: $6.67


Adagio Therapeutics Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $5.33313. Pessimistic: $4.55. Optimistic: $6.17



Adagio Therapeutics (ADGI) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 5.83 5.53 6.29 12.06
Feb 6.34 6.06 6.74 10.15
Mar 6.20 5.83 7.11 18.12
Apr 6.53 5.53 7.43 25.66
May 5.77 5.49 6.64 17.39
Jun 6.09 5.68 7.03 19.20
Jul 5.16 4.56 5.55 17.84
Aug 5.31 4.76 5.64 15.60
Sep 5.88 5.01 6.67 24.87
Oct 5.95 5.20 6.21 16.28
Nov 5.75 5.17 6.13 15.57
Dec 6.71 6.05 7.06 14.26

Adagio Therapeutics (ADGI) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 7.57 7.21 8.34 13.61
Feb 6.86 5.98 7.70 22.28
Mar 5.80 4.90 6.59 25.70
Apr 5.40 4.71 6.21 24.17
May 4.87 4.47 5.48 18.47
Jun 4.42 4.23 4.91 13.87
Jul 4.77 4.52 5.16 12.57
Aug 4.32 4.14 4.76 13.04
Sep 4.82 4.62 5.35 13.51
Oct 4.69 4.13 4.93 16.19
Nov 4.07 3.88 4.49 13.61
Dec 4.20 3.60 4.59 21.61

Adagio Therapeutics (ADGI) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 4.18 3.52 4.40 20.11
Feb 3.57 3.15 3.89 19.23
Mar 4.19 3.61 4.82 25.04
Apr 4.78 4.50 5.47 17.83
May 5.17 4.76 5.93 19.72
Jun 5.19 4.58 5.54 17.26
Jul 5.79 4.95 6.09 18.63
Aug 6.64 6.14 6.91 11.15
Sep 7.55 6.90 8.12 15.06
Oct 7.50 6.47 8.09 20.04
Nov 7.38 6.91 8.49 18.61
Dec 6.44 5.68 7.31 22.36

Adagio Therapeutics (ADGI) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 6.68 5.95 7.68 22.61
Feb 7.18 6.73 7.95 15.34
Mar 7.36 6.86 8.39 18.25
Apr 8.53 7.23 9.41 23.19
May 10.20 9.20 11.28 18.45
Jun 9.97 8.60 10.77 20.19
Jul 10.43 9.39 11.70 19.79
Aug 11.54 10.78 12.34 12.71
Sep 11.47 10.11 12.48 18.93
Oct 10.78 9.25 11.69 20.85
Nov 11.40 9.74 13.07 25.48
Dec 12.18 10.38 13.67 24.06

Adagio Therapeutics information and performance

Adagio Therapeutics Address

N/A

Market Capitalization: N/A $

Market capitalization of the Adagio Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ADGI shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Adagio Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.